As depression apps proliferate, physicians face important questions. What should they know, and do these tools have a role in ...
With Rebrand and US Launch of Depression Test, NeuroKaire Enters Precision Psychiatry Testing Market
The BrightKaire test converts stem cells to neurons and exposes those neurons to different antidepressants to determine how ...
SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced the publication of a new meta ...
Hosted on MSN
Genetic test can reveal risk of late-life depression
A world-first study has shown that it is possible to determine who is likely to get depression in late-life based on a "genetic score." The longitudinal study of more than 12,000 people over 70 paves ...
The funding includes €2 million ($2.35 million) in seed investment from Critical Path Ventures and €1 million ($1.18 million) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback